CClinicalTrials.gg
CompletedNCT06829992Updated Nov 24, 2025

Effects of Applying Kinesio Tapping on Primary Dysmenorrhea in Football Players

An interventional study of Kinesio Taping and Placebo Group in Primary Dysmenorrhea (PD), sponsored by Federal University of São Paulo. Completed at 1 site in Brazil. Open to female participants aged 15 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Federal University of São Paulo · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
15 Years to 17 Years
Sex
Female
01

Study summary

The objective of this clinical study is to investigate the effects of applying Kinesio Taping to female soccer players with PD and comparing this application with a placebo group.

Read the detailed description

Women's football has grown in the last decade, but there is still a need to study how the menstrual cycle affects players' performance. Primary Dysmenorrhea (PD), a common menstrual pain, impacts between 50% and 90% of women, reducing their participation in sporting activities. Many players notice that their performance is affected during the cycle, and the use of anti-inflammatories is not always effective. Therefore, it is important to implement simple measures that improve the quality of life and performance of players. Alternatives such as physical therapy and Kinesio Taping (KT) can help alleviate symptoms. The literature shows that KT is a technique with the potential to produce tactile sensory impulses on the skin, which can block or reduce the arrival of painful sensations to the brain, and could therefore be interesting in the treatment of PD. Therefore, the present study aims to investigate the effects of applying Kinesio Taping to female soccer players with PD and comparing this application with a placebo group.

02

Conditions studied

  • Primary Dysmenorrhea (PD)

Keywords

  • primary dysmenorrhea
  • kinesio taping
  • female football
03

In context

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 17 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women practicing football from the Mulheres em Campo project
  • Primary dysmenorrhea
  • Aged between 15 and 17 years
  • Regular menstrual cycle (28 ± 7 days)
  • Nulliparous
  • Not having an intrauterine contraceptive device or using oral contraceptives
  • DP will be defined according to the Visual Analogue Scale from 5 points.

Exclusion criteria

Exclusion Criteria:

  • Women who do not play football in the Mulheres em Campo project
  • Secondary dysmenorrhea
  • Diagnosed with serious comorbidity
  • Skin lesions in the abdominal region
  • Allergy to adhesive tapes.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Kinesio Taping group

    KT will be applied by a physiotherapist with experience in the Kinesio Taping method by Kenzo Kase. Three I-shaped Kinesio tapes will be used, 5 cm wide, covering the T-11 and T-12 dermatomes. The first tape will be applied vertically between the navel and pubis, with the participant in an orthostatic position with slight trunk extension. The second tape, with the same length as the first, will be applied with its central region over the middle zone of the first, perpendicularly. The third tape will be applied horizontally to the lower back, covering the spines posterosuperior iliac muscles, with the participant in an orthostatic position, performing light trunk flexion.

    Device: Kinesio Taping

  • Placebo comparator
    placebo group

    The quantity of tapes, type, size and region of application will be the same as the group KT, however, in this group the tapes will be applied without tension and with procedure different from that recommended, first starting to adhere a side anchor into the skin, followed by the center and then the other side anchor.

    Device: Placebo Group

Interventions

  • DeviceKinesio Taping

    KT will be applied by a physiotherapist with experience in the Kinesio Taping method by Kenzo Kase. Three I-shaped Kinesio tapes will be used, 5 cm wide, covering the T-11 and T-12 dermatomes. The first tape will be applied vertically between the navel and pubis, with the participant in an orthostatic position with slight trunk extension. The second tape, with the same length as the first, will be applied with its central region over the middle zone of the first, perpendicularly. The third tape will be applied horizontally to the lower back, covering the spines posterosuperior iliac muscles, with the participant in an orthostatic position, performing light trunk flexion.

    Also known as: Taping, Tape

  • DevicePlacebo Group

    The quantity of tapes, type, size and region of application will be the same as the group KT, however, in this group the tapes will be applied without tension and with procedure different from that recommended, first starting to adhere a side anchor into the skin, followed by the center and then the other side anchor.

    Also known as: placebo

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale

    Visual Analogue Scale (VAS): to assess the intensity of menstrual pain. 10 cm VAS, which proved to be a valid and reliable tool for measuring experimental and clinical pain. The VAS is scored on a horizontal line of 10 points (0 = no pain and 10 = maximum pain). Participants must mark the intensity of menstrual pain on the horizontal line, considering the most painful days of the menstrual cycle.

    Time frame: At recruitment and at the end of the menstrual cycle of each of the four months of the study (each cycle is 28 days).

Secondary outcomes

  1. Short McGill

    Assessment of subjective pain in relation to PD. Shortened version of the original McGill questionnaire, translated and validated into Portuguese. The person assessed must choose one of 15 words and the pain is classified according to its sensory and affective dimensions, along with an analogue scale that assesses the general intensity of the pain in the last few days and a 6-item scale with a global description of the intensity. The questionnaire score is calculated based on the intensity of the pain descriptors chosen by the patient. Being the intensity scale 0 = none, 1 = mild, 2 = uncomfortable, 3 = distressing, 4 = horrible, 5 = excruciating. The pain index is obtained by adding the intensity values of the chosen descriptors. The highest possible value is 20, as the patient can only choose one word per subgroup. The higher the total score, the greater the patient's pain experience.

    Time frame: At recruitment and at the end of the menstrual cycle of each of the four months of the study (each cycle is 28 days)

  2. Menstrual complaints questionnaire

    Assessment of the presence of low back pain, headache, abdominal swelling, breast tenderness, fatigue, nausea, vomiting, diarrhea, constipation, insomnia, nervousness and depression. Responses will be recorded as "present" or "absent" on a questionnaire

    Time frame: At recruitment and at the end of the menstrual cycle of each of the four months of the study (each cycle is 28 days)

  3. Questionnaire on interference of Primary Dysmenorrhea in sports practice

    Assessment of how much the symptoms of primary dysmenorrhea interfered with their sports practice. The responses will be recorded as "almost no interference", "little interference", "medium interference", "a lot of interference", "intense interference".

    Time frame: At recruitment and at the end of the menstrual cycle of each of the four months of the study (each cycle is 28 days)

  4. Short form health survey 36 (sf-36)

    Assessment of quality of life. Translated and validated version into Portuguese of the Short Form Health Survey 36. The SF-36 assesses eight aspects of quality of life: Functional capacity, Physical aspects, Emotional aspects, Pain, General health status, Vitality, Social aspects, Mental health. Your score ranges from 0 to 100, with 0 being the worst health status and 100 being the best.

    Time frame: At recruitment and at the end of the menstrual cycle of each of the four months of the study (each cycle is 28 days)

  5. Diary menstrual

    Paper diary where they must record with a pen every time they take medication due to discomfort related to dysmenorrhea in each menstrual cycle, as well as the intensity of the discomfort (mild, moderate, intense).

    Time frame: Every day of the menstrual cycle throughout the four months of the study (each cycle is 28 days)

07

Study locations

1 site
  • Department of Gynecology of Federal University of São Paulo
    São Paulo, São Paulo 04021-001, Brazil
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) will not be authorized because the sample is made up of minors and the information collected is confidential. After the study is completed, the results will be duly published in accordance with ethical standards.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06829992
Lead sponsor
Federal University of São Paulo
Responsible party
Maíta Poli de Araújo (Principal Investigator, Federal University of São Paulo) — Principal investigator
First posted
Feb 17, 2025
Start date
May 26, 2025
Primary completion
Sep 27, 2025
Completion
Nov 18, 2025
Last update
Nov 24, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion